Kymera Signs a DNA-Encoded Library Based Drug Discovery Research Agreement with HitGen

 Kymera Signs a DNA-Encoded Library Based Drug Discovery Research Agreement with HitGen

Kymera Signs a DNA-Encoded Library Based Drug Discovery Research Agreement with HitGen

Shots:

  • HitGen to receive upfront and milestones from Kymera. The companies collaborated to identify small molecule leads against targets of interest to Kymera
  • HitGen will leverage its platform technology based on DNA-encoded libraries (DEL) to discover compounds, that will be exclusively licensed to Kymera
  • HitGen’s DELs include encoded syntheses for hundreds of millions of novels, diverse, drug-like small molecule and macrocycle compounds

Click here to­ read full press release/ article | Ref: HitGen | Image: LinkedIn

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post